Edition:
United States

CytoDyn Inc (CYDY.PK)

CYDY.PK on OTC Markets Group

0.62USD
3:48pm EDT
Change (% chg)

$-0.01 (-1.74%)
Prev Close
$0.63
Open
$0.63
Day's High
$0.65
Day's Low
$0.61
Volume
146,072
Avg. Vol
275,859
52-wk High
$1.57
52-wk Low
$0.57

CYDY.PK

Chart for CYDY.PK

About

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the clinical development and commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The Company's lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $93.57
Shares Outstanding(Mil.): 149.47
Dividend: --
Yield (%): --

Financials

  CYDY.PK Industry Sector
P/E (TTM): -- 47.76 29.98
EPS (TTM): -0.19 -- --
ROI: -675.35 -2.36 13.08
ROE: -1,676.87 5.29 14.23

BRIEF-CytoDyn updates on Pro 140 late-stage trial

* CytoDyn files protocol for extended access to PRO 140 for patients who reach the end of PRO 140 pivotal phase 3 trial

Oct 24 2016

More From Around the Web

Earnings vs. Estimates